About: Invasive strategy for COVID patients presenting with acute coronary syndrome: The first multicenter Italian experience

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Invasive strategy for COVID patients presenting with acute coronary syndrome: The first multicenter Italian experience Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Invasive strategy for COVID patients presenting with acute coronary syndrome: The first multicenter Italian experience
Creator	Bosco, Audo, Andrea Kozel, Daniela Pistis, Gianfranco Secco, Gioel Tarantini, Giuseppe Vercellino, Matteo Centini, Giacomo Maggio, Silvia Parisi, Rosario Mario, Carlo Garbo, Roberto Mazzarotto, Pietro Econ, Bsc San, Giovanni
Source	Medline; PMC
abstract	OBJECTIVE: To report our initial experience of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)/acute coronary syndrome (ACS) patients undergoing standard of care invasive management. BACKGROUND: The rapid diffusion of the SARS‐CoV‐2 together with the need for isolation for infected patients might be responsible for a suboptimal treatment for SARS‐CoV‐2 ACS patients. Recently, the group of Sichuan published a protocol for COVID/ACS infected patients that see the thrombolysis as the gold standard of care. METHODS: We enrolled 31 consecutive patients affected by SARS‐COV‐2 admitted to our emergencies room for suspected ACS. RESULTS: All patients underwent urgent coronary angiography and percutaneous coronary intervention (PCI) when required except two patients with severe hypoxemia and unstable hemodynamic condition that were conservatively treated. Twenty‐one cases presented diffuse ST‐segment depression while in the remaining cases anterior and inferior ST‐elevation was present in four and six cases, respectively. PCI was performed in all cases expect two that were diagnosed as suspected myocarditis because of the absence of severe coronary disease and three with apical ballooning at ventriculography diagnostic for Tako‐Tsubo syndromes. Two patients conservatively treated died. The remaining patients undergoing PCI survived except one that required endotracheal intubation (ETI) and died at Day 6. ETI was required in five more patients while in the remaining cases CPAP was used for respiratory support. CONCLUSIONS: Urgent PCI for ACS is often required in SARS‐CoV‐2 patients improving the prognosis in all but the most advanced patients. Complete patient history and examination, routine ECG monitoring, echocardiography, and careful evaluation of changes in cardiac enzymes should be part of the regular assessment procedures also in dedicated COVID positive units.
has issue date	2020-05-12(xsd:dateTime)
bibo:doi	10.1002/ccd.28959
bibo:pmid	32400049
has license	no-cc
sha1sum (hex)	2bdf713b875058bc6a33d417f94f64b3819b4462
schema:url	https://doi.org/10.1002/ccd.28959
resource representing a document's title	Invasive strategy for COVID patients presenting with acute coronary syndrome: The first multicenter Italian experience
has PubMed Central identifier	PMC7272920
has PubMed identifier	32400049
schema:publication	Catheter Cardiovasc Interv
resource representing a document's body	covid:2bdf713b875058bc6a33d417f94f64b3819b4462#body_text
is schema:about of	named entity 'management' named entity 'ACS' named entity 'SARS-CoV-2' named entity 'COVID' named entity 'acute coronary syndrome' named entity 'coronavirus' named entity 'severe acute respiratory syndrome coronavirus 2' named entity 'chest X-ray' named entity 'SARS' named entity 'NSTEMI' named entity 'loading dose' named entity 'coronavirus' named entity 'hypoxemia' named entity 'percutaneous coronary intervention' named entity 'activated clotting time' named entity 'China' named entity 'MERS-CoV' named entity 'Wuhan' named entity 'WHO' named entity 'biomarkers' named entity 'NSTEMI' named entity 'intensive therapy unit' named entity 'dry cough' named entity 'aspirin' named entity 'STEMI' named entity 'Intravenous' named entity 'COVID' named entity 'SARS' named entity 'cardiac death' named entity 'heparin' named entity 'GP IIb/IIIa' named entity 'fever' named entity 'nCoV' named entity 'hemodynamics' named entity 'dyspnea' named entity 'ARDS' named entity 'fully disposable' named entity 'risk factors' named entity 'STEMI' named entity 'China' named entity 'renal dysfunction' named entity 'ACS' named entity 'ICU' named entity 'edema' named entity 'Interstitial pneumonia' named entity 'respiratory tract' named entity 'respiratory failure' named entity 'slight delay' named entity 'mortality rate' named entity 'stent' named entity 'fever' named entity 'respiratory care' named entity 'ACS' named entity 'dyspnea' named entity 'intravenous' named entity 'STEMI' named entity 'Cangrelor' named entity 'reperfusion' named entity 'World Health Organization' named entity 'dry cough' named entity 'SARS-CoV-2' named entity 'symptom' named entity 'interventional cardiology' named entity 'troponin' named entity 'surgical mask' named entity 'intubated' named entity 'standard of care'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software